Karaaǧaç, M. Et Al. 2023. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer. Journal of Cancer Research and Therapeutics , vol.19, no.5 , 1248-1254.

Karaaǧaç, M., Geredeli, Ç., Yildirim, M. S., Altinok, T., Dede, İ., İNAL, A., ... Zamani, A. G.(2023). The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer. Journal of Cancer Research and Therapeutics , vol.19, no.5, 1248-1254.

Karaaǧaç, Mustafa Et Al. "The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer," Journal of Cancer Research and Therapeutics , vol.19, no.5, 1248-1254, 2023

Karaaǧaç, Mustafa Et Al. "The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer." Journal of Cancer Research and Therapeutics , vol.19, no.5, pp.1248-1254, 2023

Karaaǧaç, M. Et Al. (2023) . "The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer." Journal of Cancer Research and Therapeutics , vol.19, no.5, pp.1248-1254.

@article{article, author={Mustafa Karaaǧaç Et Al. }, title={The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer}, journal={Journal of Cancer Research and Therapeutics}, year=2023, pages={1248-1254} }